Advisory Alpha’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
9,001
-520
| -5% | -$24.1K | 0.01% | 297 |
|
|
2025
Q1 | $581K | Buy |
9,521
+883
| +10% | +$53.9K | 0.02% | 225 |
|
|
2024
Q4 | $489K | Sell |
8,638
-1,128
| -12% | -$63.8K | 0.02% | 236 |
|
|
2024
Q3 | $505K | Buy |
9,766
+563
| +6% | +$29.1K | 0.02% | 233 |
|
|
2024
Q2 | $382K | Sell |
9,203
-845
| -8% | -$35.1K | 0.02% | 254 |
|
|
2024
Q1 | $545K | Buy |
10,048
+4,245
| +73% | +$230K | 0.02% | 206 |
|
|
2023
Q4 | $298K | Buy |
+5,803
| New | +$298K | 0.01% | 259 |
|
|
2023
Q1 | – | Sell |
-3,407
| Closed | -$245K | – | 283 |
|
|
2022
Q4 | $245K | Buy |
3,407
+16
| +0.5% | +$1.15K | 0.02% | 228 |
|
|
2022
Q3 | $241K | Sell |
3,391
-90
| -3% | -$6.4K | 0.02% | 219 |
|
|
2022
Q2 | $268K | Buy |
3,481
+113
| +3% | +$8.7K | 0.02% | 213 |
|
|
2022
Q1 | $246K | Buy |
3,368
+110
| +3% | +$8.03K | 0.02% | 236 |
|
|
2021
Q4 | $203K | Buy |
+3,258
| New | +$203K | 0.01% | 255 |
|
|
2020
Q4 | – | Sell |
-1,103
| Closed | -$67K | – | 168 |
|
|
2020
Q3 | $67K | Buy |
+1,103
| New | +$67K | 0.01% | 180 |
|
|
2020
Q2 | – | Sell |
-1,039
| Closed | -$63.3K | – | 148 |
|
|
2020
Q1 | $63.3K | Sell |
1,039
-1
| -0.1% | -$61 | 0.02% | 182 |
|
|
2019
Q4 | $68.8K | Sell |
1,040
-129
| -11% | -$8.54K | 0.02% | 238 |
|
|
2019
Q3 | $59.4K | Buy |
+1,169
| New | +$59.4K | 0.02% | 226 |
|
|
2019
Q2 | – | Sell |
-1,117
| Closed | -$52.7K | – | 175 |
|
|
2019
Q1 | $52.7K | Buy |
+1,117
| New | +$52.7K | 0.02% | 230 |
|